Summary
Concanavalin A-induced suppressor cell activity was found moderately but significantly (P<0.05) decreased in RA patients treated with nonsteroidal antiinflammatory drugs (31±7% suppression) as compared to patients on remission-inducing drugs, such as gold, penicillamine, or chloroquine (51±6%) or to healthy individuals (50±6%). Also, lymphocytes from patients with antibodies to collagen mediated lower suppression (33±7%) than lymphocytes from patients without evidence for these autoantibodies (61±11%). No significant difference between patients and controls or between individual groups of patients were observed in regard to IgM and IgG secretion induced by pokeweed mitogen. Thus, although no indication for a severe derangement of regulatory cells in peripheral blood of RA patients could be observed in this study, a slight deficiency of ConA-inducible suppressor cells that may be reverted by remission-inducing drugs seems to be present in RA.
Similar content being viewed by others
References
Waldmann TA, Broder S, Blaese RM, Durm M, Blackman M, Strober W (1974) Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinemia. Lancet II:609–613
Shou L, Schwartz SA, Good RA (1976) Suppressor cell activity after Concanavalin A treatment of lymphocytes from normal donors. J Exp Med 143:1100–1110
Bresnihan B, Jasin HE (1977) Suppressor function of peripheral blood mononuclear cells in normal individuals and patients with systemic lupus erythematosus. J Clin Invest 59:106–116
Sakane T, Steinberg AD, Green I (1978) Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum 21:657–664
Sagawa A, Abdou NI (1978) Suppressor cell dysfunction in systemic lupus erythematosus — cells involved and in vitro correction. J Clin Invest 62:789–796
Strelkauskas AJ, McCallery RT, McDowell J, Borel Y, Schlossman SF (1978) Direct evidence for loss of human suppressor cell activity during active autoimmune disease. Proc Natl Acad Sci USA 10:5150–5154
Hodgson HJF, Wands JR, Iselbacher KJ (1978) Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol 32:451–458
Smolen JS, Gangl A, Menzel EJ, Wolf Ch, Knapp W (submitted) Lymphocyte transformation and suppressor cell activity in inflammatory bowel disease
Zvaifler NJ (1973) The immunopathology of joint inflammation in theumatoid arthritis. Adv Immunol 16:265–336
Steffen C (1970) Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity. Z Immunitätsforsch Immunobiol 139:219–227
Johnson PM, Faulk WP (1976) Rheumatoid factor: Its nature, specificity, and production in rheumatoid arthritis. Clin Immunol Immunopathol 7:414–430
Notman DD, Kurata N, Tan EM (1975) Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Int Med 83:464–469
Menzel J, Steffen C, Kolarz G, Scherak O, Smolen JS (1978) Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay. Arthritis Rheum 21:243–248
Hay FC, Nineham LG, Perumal R, Roitt IM (1979) Intraarticular and circulating immune complexes and antiglobulins (IgG and IgM) in rheumatoid arthritis: correlation with clinical features. Ann Rheum Dis 38:1–7
Weisbart RH, Bluestone R, Goldberg LS (1975) Cellular immunity to autologous IgG in rheumatoid arthritis and rheumatoid like disorders. Clin Exp Immunol 20:409–417
Smolen JS, Menzel EJ, Scherak O, Kojer M, Kolarz G, Steffen C, Mayr WR (1980) Lymphocyte transformation to denatured type I collagen and B lymphocyte alloantigens in rheumatoid arthritis. Arthritis Rheum 23:424–432
Reinertsen JL, Klippel JH, Johnson AH, Steinberg AD, Decker JL, Mann DL (1978) B-lymphocyte alloantigens associated with systematic lupus erythematosus. N Engl J Med 299:515–518
Scherak O, Smolen JS, Mayr WR (1979) Prevalence of HLA DRw2 not increased in systemic lupus erythematosus. N Engl J Med 301:612
Stastny P, Fink CW (1979) Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest 63:124–130
Stastny P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298:869–871
Scherak O, Smolen JS, Mayr WR (1980) Rheumatoid arthritis and B lymphocyte alloantigen HLA DRw4. J Rheumatol 7:9–12
Abdou NI, Pascual E, Racela LS (1979) Suppressor T cell dysfunction and anti suppressor T cell antibody in active early rheumatoid arthritis. Arthritis Rheum 22:586 (Abstr)
Chattopadhyay C, Chattopadhyay H, Natvig JB, Michaelsen TE, and Mellbye OJ (1979) Lack of suppressor cell activity in rheumatoid synovial lymphocytes. Scand J Immunol 10:309–316
Chattopadhyay C, Chattopadhyay H, Natvig JB, Mellbye OJ (1979) Rheumatoid synovial lymphocytes lack concanavalin-A-activated suppressor cell activity. Scand J Immunol 10:479–486
Jasin HE, Ziff M (1975) Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum 18:219–228
Tsoukas KD, Carson DA, Fong S, Pasquali JL, Vaughan JH (1980) Cellular requirements for pokeweed mitogen-induced autoantibody production in rheumatoid arthritis. J Immunol 125:1125–1129
Koopman WJ, Schrohenloher RE (1980) Enhanced in vitro synthesis of IgM rheumatoid factor in rheumatoid arthritis. Arthritis Rheum 23:985–992
Nies KM, Louie JS (1978) Impaired immunoglobulin synthesis by peripheral blood lymphocytes in systemic lupus erythematosus. Arthritis Rheum 21:51–57
Fauci AS, Steinberg AD, Haynes BF, Whalen G (1978) Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol 121:1473–1479
Rodnan GP, McEwen C, Wallace SL (eds) (1973) Diagnostic criteria for rheumatoid arthritis. Primer on the rheumatic diseases. JAMA 224 (Suppl 5):137
Steinbrocker O, Traeger CH, Battermann RC (1949) Therapeutic criteria in rheumatoid arthritis (1. Classification of progression of rheumatoid arthritis). JAMA 140:659–662
Pehamberger H, Smolen JS, Menzel J (1980) Failure to detect C1q binding immune complexes in dermatitis herpetiformis. Arch Dermatol Res 268:101–103
Menzel EJ, Kassl M, Smoler JS, Steffen C (in press) A solid phase radioimmunoassay for the quantitation of antibodies to type I, II, and III. Immunol Lett
Knapp W, Baumgartner G (1978) Monocyte-mediated suppression of human B lymphocyte differentiation in vitro. J Immunol 121:1177–1183
Rice L, Laughter AH, Twomey JJ: Three suppressor systems in human blood that modulate lymphoproliferation. J Immunol 122:991–996
Hallgren HM, Yunis EJ: Suppressor lymphocytes in young and aged humans. J Immunol 118:2004–2009
Antel JP, Weinrich M, Arnason BG (1978) Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol 9:134–141
Sakane T, Steinberg AD, Green I (1980) Studies of immune functions of patients with systemic lupus eythematosus. V. T cell suppressor function and autologous mixed lymphocyte reaction during active and inactive phases of disease. Arthritis Rheum 23:225–231
Scherak O, Smolen JS, Mayr WR (1980) HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum 23:954–957
Miller KB, Schwartz RS (1979) Familial abnormalities of suppressor function in systemic lupus erythematosus. N Engl J Med 301:803–809
Author information
Authors and Affiliations
Additional information
National Blood Group Reference Laboratory (WHO), National Tissue Ty** Reference Laboratory (Council of Europe
Rights and permissions
About this article
Cite this article
Smolen, J.S., Lanzer, G., Scherak, O. et al. Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis: Correlation with clinical and immunological parameters. Rheumatol Int 1, 115–120 (1981). https://doi.org/10.1007/BF00541255
Issue Date:
DOI: https://doi.org/10.1007/BF00541255